154 related articles for article (PubMed ID: 8647853)
1. HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44.
Luescher IF; Romero P; Kuznetsov D; Rimoldi D; Coulie P; Cerottini JC; Jongeneel CV
J Biol Chem; 1996 May; 271(21):12463-71. PubMed ID: 8647853
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of a radioiodinated photoreactive MAGE-1 peptide derivative and photoaffinity labeling of cell-associated human leukocyte antigen-A1 molecules.
Anjuère F; Layer A; Cerottini JC; Servis C; Luescher IF
Anal Biochem; 1995 Jul; 229(1):61-7. PubMed ID: 8533896
[TBL] [Abstract][Full Text] [Related]
3. Characterization of antigenic peptides presented by HLA-B44 molecules on tumor cells expressing the gene MAGE-3.
Fleischhauer K; Fruci D; Van Endert P; Herman J; Tanzarella S; Wallny HJ; Coulie P; Bordignon C; Traversari C
Int J Cancer; 1996 Nov; 68(5):622-8. PubMed ID: 8938145
[TBL] [Abstract][Full Text] [Related]
4. A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes.
Oiso M; Eura M; Katsura F; Takiguchi M; Sobao Y; Masuyama K; Nakashima M; Itoh K; Ishikawa T
Int J Cancer; 1999 May; 81(3):387-94. PubMed ID: 10209953
[TBL] [Abstract][Full Text] [Related]
5. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
[TBL] [Abstract][Full Text] [Related]
6. A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18.
Bilsborough J; Panichelli C; Duffour MT; Warnier G; Lurquin C; Schultz ES; Thielemans K; Corthals J; Boon T; van der Bruggen P
Tissue Antigens; 2002 Jul; 60(1):16-24. PubMed ID: 12366779
[TBL] [Abstract][Full Text] [Related]
7. Differences in the recognition by CTL of peptides presented by the HLA-B*4402 and the HLA-B*4403 molecules which differ by a single amino acid.
Herman J; Jongeneel V; Kuznetsov D; Coulie PG
Tissue Antigens; 1999 Feb; 53(2):111-21. PubMed ID: 10090611
[TBL] [Abstract][Full Text] [Related]
8. A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3.
Herman J; van der Bruggen P; Luescher IF; Mandruzzato S; Romero P; Thonnard J; Fleischhauer K; Boon T; Coulie PG
Immunogenetics; 1996; 43(6):377-83. PubMed ID: 8606058
[TBL] [Abstract][Full Text] [Related]
9. Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy.
Boisgerault F; Khalil I; Tieng V; Connan F; Tabary T; Cohen JH; Choppin J; Charron D; Toubert A
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3466-70. PubMed ID: 8622959
[TBL] [Abstract][Full Text] [Related]
10. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.
Gaugler B; Van den Eynde B; van der Bruggen P; Romero P; Gaforio JJ; De Plaen E; Lethé B; Brasseur F; Boon T
J Exp Med; 1994 Mar; 179(3):921-30. PubMed ID: 8113684
[TBL] [Abstract][Full Text] [Related]
11. Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population.
DiBrino M; Parker KC; Margulies DH; Shiloach J; Turner RV; Biddison WE; Coligan JE
Biochemistry; 1995 Aug; 34(32):10130-8. PubMed ID: 7543776
[TBL] [Abstract][Full Text] [Related]
12. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.
Chaux P; Luiten R; Demotte N; Vantomme V; Stroobant V; Traversari C; Russo V; Schultz E; Cornelis GR; Boon T; van der Bruggen P
J Immunol; 1999 Sep; 163(5):2928-36. PubMed ID: 10453041
[TBL] [Abstract][Full Text] [Related]
13. A new tumor-specific antigen encoded by MAGE-C2 and presented to cytolytic T lymphocytes by HLA-B44.
Godelaine D; Carrasco J; Brasseur F; Neyns B; Thielemans K; Boon T; Van Pel A
Cancer Immunol Immunother; 2007 Jun; 56(6):753-9. PubMed ID: 17096150
[TBL] [Abstract][Full Text] [Related]
14. HLA class I self peptides isolated from a T-cell leukemia reveal the allele-specific motif of HLA-B38.
Colovai AI; Suciu-Foca N; Baiulescu GE; Harris PE
Tissue Antigens; 1994 Aug; 44(2):65-72. PubMed ID: 7817380
[TBL] [Abstract][Full Text] [Related]
15. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
[TBL] [Abstract][Full Text] [Related]
16. Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.
Chames P; Hufton SE; Coulie PG; Uchanska-Ziegler B; Hoogenboom HR
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7969-74. PubMed ID: 10884427
[TBL] [Abstract][Full Text] [Related]
17. Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: implication in a broad-spectrum tumor immunotherapy.
Graff-Dubois S; Faure O; Gross DA; Alves P; Scardino A; Chouaib S; Lemonnier FA; Kosmatopoulos K
J Immunol; 2002 Jul; 169(1):575-80. PubMed ID: 12077290
[TBL] [Abstract][Full Text] [Related]
18. A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules.
Luiten RM; Demotte N; Tine J; van der Bruggen P
Tissue Antigens; 2000 Jul; 56(1):77-81. PubMed ID: 10958359
[TBL] [Abstract][Full Text] [Related]
19. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
[TBL] [Abstract][Full Text] [Related]
20. A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12.
Panelli MC; Bettinotti MP; Lally K; Ohnmacht GA; Li Y; Robbins P; Riker A; Rosenberg SA; Marincola FM
J Immunol; 2000 Apr; 164(8):4382-92. PubMed ID: 10754339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]